MBCL-37. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH CLASSIC (CLMB) OR ANAPLASTIC/LARGE CELL (A/LCMB) MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS

BACKGROUND/OBJECTIVE: The introduction of German regimens, supplementing “standard” chemotherapy with both intravenous high-dose (HD-MTX) and intraventricular (IVENT-MTX) methotrexate, and North American regimens incorporating marrow-ablative chemotherapy with autologous hematopoietic cell rescue (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Finlay, Jonathan, Mynarek, Martin, Dhall, Girish, Mazewski, Claire, Grundy, Richard, Cohen, Bruce H, Robinson, Giles, Ashley, David, Stanek, Joseph R, Gajjar, Amar, Rutkowski, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715315/
http://dx.doi.org/10.1093/neuonc/noaa222.513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715315/
http://dx.doi.org/10.1093/neuonc/noaa222.513

Ejemplares similares